Financial Data and Key Metrics Changes - Organic sales grew 2% compared to a strong base period of 7% growth, with volume contributing 1 point and pricing adding another 1 point [4][10] - Core earnings per share (EPS) were 1.93,up54.4 billion to shareholders this quarter, including over 2.4billionindividendsandover1.9 billion in share repurchases [7][12] - The company plans to pay around 10billionindividendsandrepurchase6 billion to $7 billion in common stock for the fiscal year [12] Q&A Session Summary Question: Concerns about growth trajectory and market deceleration - Management acknowledged the challenges in markets like China and the Middle-East but emphasized strong performance in North America and Europe, which constitute 85% of sales [15][16] Question: Risks around market share and consumer behavior - Management highlighted that consumers continue to trade up within their product categories, maintaining share growth in the US and Europe despite external pressures [19][20] Question: Gross margins and cost of goods sold inflation - Management indicated that productivity improvements are the main driver of gross margin progress, with expectations for continued contributions from cost savings initiatives [25][26] Question: Performance of specific business segments - Management noted that the family care business remains stable and sustainable, while the baby care segment faces challenges due to declining birth rates [29][30] Question: Market share performance and future opportunities - Management expressed confidence in market share growth, particularly in the US and Europe, and emphasized the importance of increasing household penetration in their categories [39][40]